Cibus, Inc. (CBUS) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-28

Key Insights

Director Urban Thomas received 9,094 stock options with a $1.50 exercise price, vesting immediately (100% on grant date), representing a significant equity grant that aligns insider interests with shareholder value.
The transaction was executed on 04/24/2026 and filed on 04/28/2026, meeting standard SEC filing timelines with no apparent delays or irregularities.
This option grant to a director suggests the company is actively compensating leadership through equity incentives, though the relatively modest grant size indicates this may be a routine annual or periodic equity award rather than a major retention package.

Want the newest filings?

This analysis covers the filing from 2026-04-28. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-28

Sr VP of Research Noel Sauer acquired 38,000 shares of Class A Common Stock at $0 price on 04/24/2026, indicating these were likely granted as compensation rather than purchased on the open market.
Sauer received 76,000 stock options with a $1.50 exercise price vesting monthly over 4 years (1/48th per month), suggesting a standard equity compensation package for a senior research executive.
Following the transaction, Sauer beneficially owns 139,879 shares of Class A Common Stock directly, demonstrating meaningful personal investment alignment with company performance.
The options grant at $1.50 per share implies the stock was trading near or below that price level in late April 2026, which could indicate either a depressed valuation or a reasonable entry point for long-term compensation.

Filed: 2026-04-28

Jason Stokes, Chief Administrative Officer, General Counsel & Corporate Secretary, acquired 57,000 shares of Class A Common Stock at $0 price on 04/24/2026, indicating a non-cash equity compensation grant rather than open market purchase.
Stokes received 114,000 stock options with a $1.50 exercise price vesting monthly over 4 years (1/48th monthly), representing significant equity incentive compensation typical of executive retention strategies.
Total beneficial ownership increased to 167,865 shares following the transaction, demonstrating management's continued stake alignment with shareholders at this executive level.
The zero-price stock acquisition combined with low-priced options suggests potential equity issuance as part of compensation package, which could be dilutive to existing shareholders depending on authorization limits.

Filed: 2026-04-28

CFO Carlo Broos acquired 57,000 shares of Class A Common Stock at $0 price on 04/24/2026, indicating a grant or equity compensation event rather than open market purchase.
Broos received 114,000 stock options with a $1.50 exercise price vesting over a 10-year period (04/24/2026 to 04/24/2036), representing significant long-term equity incentive alignment with company performance.
Post-transaction beneficial ownership shows Broos holds 154,275 Class A shares directly, suggesting meaningful insider stake in the company and confidence in CBUS's future direction.
The use of an attorney-in-fact (Jason Stokes) to execute the filing is standard administrative procedure and does not indicate any unusual circumstances or concerns.

Filed: 2026-04-28

Chief Scientific Officer Gregory Francis William Gocal acquired 57,000 shares of Class A Common Stock at $0 price on 04/24/2026, indicating a stock grant or equity compensation award rather than open market purchase.
Gocal received 114,000 stock options with a $1.50 exercise price vesting monthly over 4 years, demonstrating management confidence in the company's future valuation and aligning executive incentives with long-term shareholder value.
Total beneficial ownership increased to 422,890 shares following the transaction, showing substantial insider holdings by a key executive, though the $0 acquisition price suggests compensation-based rather than conviction-based buying.

Filed: 2026-04-28

Interim CEO Peter Beetham acquired 195,000 shares of Class A Common Stock at $0 price on 04/24/2026, indicating either a grant as part of compensation or equity restructuring rather than market purchase.
Beetham received 390,000 stock options with a $1.50 exercise price vesting over 4 years (1/48th monthly), representing significant incentive alignment with 48-month vesting schedule typical for executive retention.
Following these transactions, Beetham's total beneficial ownership increased to 686,825 shares, demonstrating substantial personal stake in company performance as Interim CEO.
The use of an attorney-in-fact (Jason Stokes) to sign the Form 4 and the interim nature of the CEO title suggest potential transition period or governance considerations at the company.

Filed: 2026-04-01

The reporting person, Gregory Francis William Gocal, is the Chief Scientific Officer and Executive Vice President of Cibus, Inc., indicating their key role within the company.
Gocal disposed of 8,954 shares of Class A Common Stock at a weighted average price of $1.82 per share, suggesting they may be reducing their stake in the company.
The transaction was reported in a timely manner through the filing of a Form 4 with the SEC, indicating transparency around insider trading activities.

Filed: 2026-04-01

Noel Sauer, the Sr VP of Research at Cibus, Inc. (CBUS), sold 1,763 shares of the company's Class A common stock on March 30, 2026 at an average price of $1.84 per share.
Sauer's holdings of Cibus, Inc. common stock decreased from 103,642 shares to 101,879 shares following this transaction.
The sale appears to be a routine transaction and not indicative of any significant change in Sauer's outlook on the company.

Filed: 2026-04-01

The reporting person, Jason Stokes, is the Chief Legal Officer, General Counsel, and Secretary of Cibus, Inc. (CBUS), and this Form 4 filing discloses his sale of 3,695 shares of Class A common stock at a weighted average price of $1.83 per share.
The sale represents a relatively small portion (3.3%) of Stokes' total beneficial ownership of 110,865 shares of Class A common stock, suggesting this may be a routine transaction rather than a significant change in his position.
The timing of the sale, on March 30, 2026, does not appear to be related to any major corporate events or announcements, based on the information provided in the filing.

Filed: 2026-04-01

Insider Carlo Broos, the CFO, sold 3,676 Class A common shares of Cibus, Inc. at an average price of $1.87 per share, reducing his direct beneficial ownership to 97,275 shares.
The sale of shares by the CFO could potentially signal their outlook on the company's short-term performance or a need for personal liquidity, which may be concerning to investors.
Investors should monitor any future insider trading activity and evaluate the company's financial health and growth prospects to determine the significance of this transaction.

Filed: 2026-04-01

Insider Peter Beetham has disposed of 16,112 shares of Cibus, Inc. (CBUS) common stock at a weighted average price of $1.85 per share.
Beetham's remaining direct beneficial ownership is 491,825 shares, indicating continued significant investment in the company.
The transaction was made pursuant to a pre-planned 10b5-1 trading plan, which suggests the sale was not driven by near-term concerns.

Filed: 2026-03-18

Carlo Broos, the CFO of Cibus, Inc., has disposed of 1,496 Class A common shares on November 11, 2025 at a price of $1.32 per share.
Broos now holds 100,951 Class A common shares directly, which is a decrease from his previous beneficial ownership.
The filing does not indicate any other transactions, such as acquisitions or option exercises, by Broos during the reported period.

Filed: 2026-03-18

Noel Sauer, the Sr VP of Research at Cibus, Inc., sold 4 shares of Class A common stock at $1.485 per share on 06/13/2025 and subsequently sold an additional 1,834 shares through a stock withholding transaction on 11/11/2025.
Sauer's net holdings decreased from 105,476 shares to 103,642 shares following these transactions, indicating a modest reduction in his direct ownership position.
The timing and relatively small size of the transactions suggest these were routine portfolio management activities and not indicative of any significant change in Sauer's confidence or outlook on the company.

Filed: 2026-03-18

Insider Jason Stokes has disposed of a significant number of shares of Cibus, Inc. (CBUS) over the past year, reducing his direct beneficial ownership from 122,874 shares to 114,560 shares.
The transactions appear to be regular, non-discretionary sales, with Stokes disposing of shares on three occasions to cover tax obligations associated with equity compensation.
The reductions in Stokes' ownership, while notable, do not suggest a broader sell-off by insiders and may be part of a planned strategy to manage his personal portfolio.

Other reports for Cibus, Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.